Santhera Pharmaceuticals Investor Relations Material

Santhera Pharmaceuticals Holding Ltd is a biopharmaceutical company focused on developing treatments for neuromuscular and rare diseases. The company specializes in innovative therapies targeting genetic and mitochondrial disorders, aiming to address conditions with high unmet medical needs. Its research and development efforts include advancing novel drug candidates through clinical trials and regulatory approvals. The company is headquartered in Pratteln, Switzerland, and its shares are listed on the SIX Swiss Exchange.